Pavan Lall And Sohini Das

Stories by Pavan Lall And Sohini Das

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com   28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

PM's lockdown address best in terms of TV ratings

PM's lockdown address best in terms of TV ratings

Rediff.com   28 Mar 2020

The telecast was viewed by 197 million Indians, higher than the Indian Premier League final which was watched by 133 million, reports Sohini Das.

'2020 is a washout for movie business'

'2020 is a washout for movie business'

Rediff.com   27 Mar 2020

'There will be two to three months of containment, and when there is normalcy, the risk is a relapse and a return to lockdowns.'

COVID-19 test: Why patients opt out of private labs

COVID-19 test: Why patients opt out of private labs

Rediff.com   27 Mar 2020

At present, the cost of testing for COVID-19 is Rs 4,500 per examination and the results are available within 24 hours. Almost 90 per cent of queries fizzle out after patients realise the cost of testing will not be borne by the government.

Govt now allows doorstep delivery of drugs

Govt now allows doorstep delivery of drugs

Rediff.com   27 Mar 2020

Medicines that fall under Schedule H category (class of prescription drugs) would be provided against a valid prescription that can be submitted either physically or over e-mail. Narcotics, psychotropics and controlled substances, though, cannot be delivered.

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Rediff.com   20 Mar 2020

Retailers and multiplex operators want mall owners to either forgo rent for the period of the shutdown or lower rent in the event the mall is open but footfalls are low.

Coronivirus: How some Indian firms are cashing in on 'fear economy'

Coronivirus: How some Indian firms are cashing in on 'fear economy'

Rediff.com   19 Mar 2020

Any concerned citizen ought to start practicing hygiene by washing their hands properly and be aware of the brands that are certified.

Foodstar, India's own version of Michelin Star rankings!

Foodstar, India's own version of Michelin Star rankings!

Rediff.com   19 Mar 2020

Culinary Culture, which is spearheading the venture, will bring globally-ranked chefs to India as well as take local chefs abroad so they can work at world-ranked eateries.

Bumpy ride ahead for electric two-wheelers

Bumpy ride ahead for electric two-wheelers

Rediff.com   17 Mar 2020

The impact for all electric two-wheelers, which are imported mostly from China, is that it will lead to price escalation that will be passed onto customers.

How companies deal with coronavirus panic

How companies deal with coronavirus panic

Rediff.com   17 Mar 2020

Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.

Coronavirus fear robs malls, multiplexes of Holi colour

Coronavirus fear robs malls, multiplexes of Holi colour

Rediff.com   8 Mar 2020

'There is a clear business impact. People are avoiding crowded places and gatherings across cities. This is hitting business, both at traditional and modern trade outlets, during the Holi season, which kicked off from Saturday,' says Praveen Khandelwal, general secretary, Confederation of All India Traders (CAIT).

Nirav Modi assets garner Rs 2.29 crore in auction

Nirav Modi assets garner Rs 2.29 crore in auction

Rediff.com   5 Mar 2020

The items which included a Porsche Panamera and a gold Cartier wristwatch were expected to fetch Rs 50 lakh.

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com   4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

Electric cars have a mountain to climb before winning market share

Electric cars have a mountain to climb before winning market share

Rediff.com   24 Feb 2020

According to research by IHS Markit, for an ecosystem still grappling with infrastructure issues -- the high cost of EVs and a greater OEM (original equipment manufacturer) focus on electrifying two-wheelers and commercial vehicles first -- the share of such vehicles is expected to be 4 per cent by 2030, reports Pavan Lall.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com   20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Kohli is top celebrity brand for third time in a row

Kohli is top celebrity brand for third time in a row

Rediff.com   17 Feb 2020

The Duff & Phelps report shows that Virat Kohli has increased his brand value by 40 per cent to $237.5 million in 2019 and taken a huge lead with his closest rival, Akshay Kumar, ranked second.

Anand Mahindra: 'I'm not vanishing!'

Anand Mahindra: 'I'm not vanishing!'

Rediff.com   14 Feb 2020

'Family businesses have to put competent people in charge who believe they can get to the top.'
'If you don't remove the glass ceiling, you won't get the best talent.'

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com   12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.